These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 24363489)

  • 21. Permutation-based variance component test in generalized linear mixed model with application to multilocus genetic association study.
    Zeng P; Zhao Y; Li H; Wang T; Chen F
    BMC Med Res Methodol; 2015 Apr; 15():37. PubMed ID: 25897803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adaptive clinical trials: progress and challenges.
    Coffey CS; Kairalla JA
    Drugs R D; 2008; 9(4):229-42. PubMed ID: 18588354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Internal pilot studies I: type I error rate of the naive t-test.
    Wittes J; Schabenberger O; Zucker D; Brittain E; Proschan M
    Stat Med; 1999 Dec; 18(24):3481-91. PubMed ID: 10611620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simple procedures for blinded sample size adjustment that do not affect the type I error rate.
    Kieser M; Friede T
    Stat Med; 2003 Dec; 22(23):3571-81. PubMed ID: 14652861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blinded sample size re-estimation in superiority and noninferiority trials: bias versus variance in variance estimation.
    Friede T; Kieser M
    Pharm Stat; 2013; 12(3):141-6. PubMed ID: 23509095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Applying the law of iterated logarithm to control type I error in cumulative meta-analysis of binary outcomes.
    Hu M; Cappelleri JC; Lan KK
    Clin Trials; 2007; 4(4):329-40. PubMed ID: 17848494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A practical comparison of group-sequential and adaptive designs.
    Kelly PJ; Sooriyarachchi MR; Stallard N; Todd S
    J Biopharm Stat; 2005; 15(4):719-38. PubMed ID: 16022175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blinded sample size re-estimation in crossover bioequivalence trials.
    Golkowski D; Friede T; Kieser M
    Pharm Stat; 2014; 13(3):157-62. PubMed ID: 24715672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Testing multiple variance components in linear mixed-effects models.
    Drikvandi R; Verbeke G; Khodadadi A; Partovi Nia V
    Biostatistics; 2013 Jan; 14(1):144-59. PubMed ID: 22930674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monte Carlo simulation of OLS and linear mixed model inference of phenotypic effects on gene expression.
    Walker JA
    PeerJ; 2016; 4():e2575. PubMed ID: 27761350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequential monitoring of covariate adaptive randomized clinical trials with sample size re-estimation.
    Yu J; Lai D
    Contemp Clin Trials; 2019 Dec; 87():105874. PubMed ID: 31678412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simultaneously correcting for population stratification and for genotyping error in case-control association studies.
    Cheng KF; Lin WJ
    Am J Hum Genet; 2007 Oct; 81(4):726-43. PubMed ID: 17846998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sample size re-estimation incorporating prior information on a nuisance parameter.
    Mütze T; Schmidli H; Friede T
    Pharm Stat; 2018 Mar; 17(2):126-143. PubMed ID: 29181869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Doubly regularized estimation and selection in linear mixed-effects models for high-dimensional longitudinal data.
    Li Y; Wang S; Song PX; Wang N; Zhou L; Zhu J
    Stat Interface; 2018; 11(4):721-737. PubMed ID: 30510614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Operating characteristics of sample size re-estimation with futility stopping based on conditional power.
    Lachin JM
    Stat Med; 2006 Oct; 25(19):3348-65. PubMed ID: 16345019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of the relative merits of a few methods to detect evolutionary trends.
    Laurin M
    Syst Biol; 2010 Dec; 59(6):689-704. PubMed ID: 20937759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sample size reassessment in non-inferiority trials. Internal pilot study designs with ANCOVA.
    Friede T; Kieser M
    Methods Inf Med; 2011; 50(3):237-43. PubMed ID: 20213039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blinded sample size re-estimation for recurrent event data with time trends.
    Schneider S; Schmidli H; Friede T
    Stat Med; 2013 Dec; 32(30):5448-57. PubMed ID: 24105855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Statistical tests with accurate size and power for balanced linear mixed models.
    Muller KE; Edwards LJ; Simpson SL; Taylor DJ
    Stat Med; 2007 Aug; 26(19):3639-60. PubMed ID: 17394132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Noncentral Chi-square Distribution in Misspecified Structural Equation Models: Finite Sample Results from a Monte Carlo Simulation.
    Curran PJ; Bollen KA; Paxton P; Kirby J; Chen F
    Multivariate Behav Res; 2002 Jan; 37(1):1-36. PubMed ID: 26824167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.